#USA #Beijing #Waterdrop Inc. #AI Medical Insurance #Digital Clinical Trial

Waterdrop Inc.'s Financial Insights for Q4 and FY2025

Waterdrop Inc. has made headlines with its significant financial advancements reported for the fourth quarter and the entire fiscal year of 2025. With a remarkable net operating revenue of 1.41 billion RMB for Q4, the company has showcased a stunning year-over-year increase of 105.5%. This surge can largely be credited to the impressive growth in their insurance sector, which drove net profit for ordinary shareholders to 162.1 million RMB, a robust increase of 62.7%. This performance marks the sixteenth consecutive quarter of profitability for Waterdrop, underscoring its continued success and market stability.

Annual Overview

For the entirety of 2025, Waterdrop's operating revenue reached 3.98 billion RMB, reflecting a 43.5% increase from the previous year. The insurance-related income significantly contributed to this growth, allowing the company to report a net profit of 568.9 million RMB, significantly up from 367.5 million RMB in 2024. This overall financial success is a testament to Waterdrop’s strategic focus and efficiency in its operations.

Shareholder Return

In a move that demonstrates its healthy cash position, Waterdrop announced a cash dividend of approximately 10.8 million USD, following the repurchase of around 60.7 million ADS from the open market. The company reported a cash position of 3.25 billion RMB (approximately 464.6 million USD) as of December 2025, offering reassurance to stakeholders about its financial health and commitment to returning value to shareholders.

Innovations in Insurance

The growth in insurance-related revenue was particularly noteworthy as it climbed by 125% year-over-year in the fourth quarter alone. Waterdrop’s innovative integration of AI technology plays a crucial role in achieving this success. The company implemented advanced AI systems that streamlined operations and improved efficiency, allowing for the rapid processing of insurance claims and customer inquiries. The AI Medical Insurance Expert increased premiums on a quarter-over-quarter basis by 145%, and the AI Customer Service Agent managed over 1.4 million inquiries in just a month.

Medical Crowdfunding Momentum

Waterdrop's commitment to social impact is evidenced through its Medical Crowdfunding platform, which raised a staggering 72.3 billion RMB for 3.68 million patients. This initiative repurposes donations towards life's urgent medical needs, making a considerable difference in the healthcare landscape. The company also enhanced its risk management practices by adopting automated systems to protect data integrity and verify fund usage appropriately.

Digital Clinical Trials

In another major stride, Waterdrop's E-Find platform, which focuses on digital clinical trials, gained substantial traction, enrolling over 14,555 patients. In Q4 2025, this segment alone reported revenues of 35.7 million RMB, marking a 39.9% year-on-year increase. They secured patents for technologies that enhance patient-trial matching efficacy, representing major advancements in clinical research supported by AI capabilities.

Looking Forward

Founder and CEO, Peng Shen, describes 2025 as a pivotal year where Waterdrop embraced technological advancements that drive operational efficiency and profit growth. As AI becomes ingrained in the company's core operations, Waterdrop seeks not only to sustain its performance but extend its impact on society, emphasizing safe and equitable healthcare solutions.

Waterdrop's journey through 2025 illustrates a broader trend of success fostered by a commitment to technology and care for its community. With an optimistic outlook, the company is well-positioned for continued success and innovation in the insurance and healthcare sectors.